These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 12473599

  • 1. Loss of pRb2/p130 expression is associated with unfavorable clinical outcome in lung cancer.
    Caputi M, Groeger AM, Esposito V, De Luca A, Masciullo V, Mancini A, Baldi F, Wolner E, Giordano A.
    Clin Cancer Res; 2002 Dec; 8(12):3850-6. PubMed ID: 12473599
    [Abstract] [Full Text] [Related]

  • 2. The role of pRb2/p130 protein in diagnosing lung carcinoma on fine needle aspiration biopsies.
    Minimo C, Bibbo M, Claudio PP, De Luca A, Giordano A.
    Pathol Res Pract; 1999 Dec; 195(2):67-70. PubMed ID: 10093823
    [Abstract] [Full Text] [Related]

  • 3. The retinoblastoma family member pRb2/p130 is an independent predictor of survival in human soft tissue sarcomas.
    Masciullo V, Berardengo E, Boglione A, Sgambato A, Bernardi A, Forni M, Linari A, Cito L, Scambia G, Comandone A, Giordano A.
    Clin Cancer Res; 2008 Aug 01; 14(15):4775-9. PubMed ID: 18676747
    [Abstract] [Full Text] [Related]

  • 4. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H, Hu SX, Fujino M, Harada M, Kinoshita I, Xu HJ, Kuzumaki N, Kawakami Y, Benedict WF.
    Cancer; 1997 Apr 01; 79(7):1329-37. PubMed ID: 9083154
    [Abstract] [Full Text] [Related]

  • 5. Reduced transcription of the RB2/p130 gene in human lung cancer.
    Xue Jun H, Gemma A, Hosoya Y, Matsuda K, Nara M, Hosomi Y, Okano T, Kurimoto F, Seike M, Takenaka K, Yoshimura A, Toyota M, Kudoh S.
    Mol Carcinog; 2003 Nov 01; 38(3):124-9. PubMed ID: 14587097
    [Abstract] [Full Text] [Related]

  • 6. pRB2/p130 target genes in non-small lung cancer cells identified by microarray analysis.
    Russo G, Claudio PP, Fu Y, Stiegler P, Yu Z, Macaluso M, Giordano A.
    Oncogene; 2003 Oct 09; 22(44):6959-69. PubMed ID: 14534545
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer.
    Chang YS, Kong G, Sun S, Liu D, El-Naggar AK, Khuri FR, Hong WK, Lee HY.
    Clin Cancer Res; 2002 Dec 09; 8(12):3796-802. PubMed ID: 12473592
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
    Han CH, Cho JY, Moon JT, Kim HJ, Kim SK, Shin DH, Chang J, Ahn CM, Kim SK, Chang YS.
    Oncol Rep; 2006 Dec 09; 16(6):1205-10. PubMed ID: 17089038
    [Abstract] [Full Text] [Related]

  • 13. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z, Ma J, Li N, Sun N, Wang C.
    Ann Thorac Surg; 2006 Jul 09; 82(1):243-8. PubMed ID: 16798222
    [Abstract] [Full Text] [Related]

  • 14. Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity.
    Kinoshita I, Dosaka-Akita H, Mishina T, Akie K, Nishi M, Hiroumi H, Hommura F, Kawakami Y.
    Cancer Res; 1996 Dec 15; 56(24):5557-62. PubMed ID: 8971152
    [Abstract] [Full Text] [Related]

  • 15. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
    Modi S, Kubo A, Oie H, Coxon AB, Rehmatulla A, Kaye FJ.
    Oncogene; 2000 Sep 21; 19(40):4632-9. PubMed ID: 11030152
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of p27KIP1 expression in resected non-small cell lung cancers: analysis in combination with expressions of p16INK4A, pRB, and p53.
    Hirabayashi H, Ohta M, Tanaka H, Sakaguchi M, Fujii Y, Miyoshi S, Matsuda H.
    J Surg Oncol; 2002 Dec 21; 81(4):177-84; discussion 184. PubMed ID: 12451621
    [Abstract] [Full Text] [Related]

  • 17. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.
    Brambilla E, Moro D, Gazzeri S, Brambilla C.
    J Pathol; 1999 Aug 21; 188(4):351-60. PubMed ID: 10440744
    [Abstract] [Full Text] [Related]

  • 18. Retinoblastoma-related p107 and pRb2/p130 proteins in malignant lymphomas: distinct mechanisms of cell growth control.
    Leoncini L, Bellan C, Cossu A, Claudio PP, Lazzi S, Cinti C, Cevenini G, Megha T, Laurini L, Luzi P, Orcioni GF, Piccioli M, Pileri S, Giardino C, Tosi P, Giordano A.
    Clin Cancer Res; 1999 Dec 21; 5(12):4065-72. PubMed ID: 10632341
    [Abstract] [Full Text] [Related]

  • 19. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
    Huang PY, Liang XM, Lin SX, Luo RZ, Hou JH, Zhang L.
    Ai Zheng; 2004 Jul 21; 23(7):845-50. PubMed ID: 15248926
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K, Kawamoto M.
    Ann Thorac Surg; 2005 Jan 21; 79(1):248-53. PubMed ID: 15620951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.